Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?

Autor:	Anaël Ayrolles, Pierre Ellul, Vincent Trebossen, Nadira Houhou‐Fidouh, Stephane Bonacorsi, Diane Descamps, Richard Delorme
Jazyk:	angličtina
Rok vydání:	2022
Předmět:	children mental health pandemic psychiatric symptoms SARS‐CoV‐2 Therapeutics. Pharmacology RM1-950 Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Zdroj:	Neuropsychopharmacology Reports, Vol 42, Iss 2, Pp 218-220 (2022)
Druh dokumentu:	article
ISSN:	2574-173X
DOI:	10.1002/npr2.12236
Popis:	ABSTRACT Aims Since the beginning of the COVID pandemic, studies reported an increase in children’s mental health issues and questioned the impact of SARS‐CoV‐2 on psychiatric symptoms. Methods We compared COVID seroconversion in children hospitalized with acute, severe psychiatric symptoms (n = 52) with the sex‐ and age‐matched control group (n = 52) living in the same low‐income geographic area and sampled during the same time period. Results Contrary to our hypothesis, we observed less seroconverted children with psychiatric conditions 9.61% (95% CI, 3.59‐21.80) vs 34.61% (95% CI, 22.33‐49.16; χ2 = 14.7, P = 1.24E−4; OR = 0.20; 95% CI, 0.05‐0.64). Conclusion This suggests a lower direct impact of SARS‐CoV‐2 compared with the impact of mitigation strategies on psychiatric symptom deterioration in children reported since early stages of the pandemic.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/4349fc6f009642539d925576d735b8f2 Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.